International Biotechnology Trust plc (the "Company")
Transaction in own shares
The Company announces that on 17 March 2020 it made a market purchase of 10,000 of its own Ordinary shares of 25p each, representing 0.026% of the issued share capital (excluding treasury shares). The shares were bought at 476.608p per share and the Company intends to hold these shares in treasury.
Following this purchase, there are 38,391,817 Ordinary shares in issue (excluding treasury shares) and 2,950,846 Ordinary shares held in treasury.
Susan Gledhill
For and on behalf of
BNP Paribas Secretarial Services Limited
Company Secretary
Telephone: 020 7410 5971
17 MARCH 2020
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:
Obtains access to the information in a personal capacity;
Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
Please note, this site uses cookies. Some of the cookies are essential for parts of the site to operate and have already been set. You may delete and block all cookies from this site, but if you do, parts of the site may not work. To find out more about the cookies used on Investegate and how you can manage them, see our Privacy and Cookie Policy
To continue using Investegate, please confirm that you are a private investor as well as agreeing to our Privacy and Cookie Policy & Terms.